Skip to main content
Funded Studies

Un Jung Kang, MD

Founders Professor of Neurology, Professor in Neuroscience Institute at New York University Grossman School of Medicine

Location: New York, NY United States

Un Jung Kang, MD, is director of translational research at the Marlene and Paolo Fresco Institute of Parkinson’s and Movement Disorders, and co-director of Parekh Center for Interdisciplinary Neurology at NYU Grossman School of Medicine. He was previously chief of Movement Disorders Division at Columbia University, founded by Dr. Stanley Fahn. Dr. Kang received his medical degree from the Johns Hopkins University and completed his neurology residency and movement disorders fellowship training at Columbia University.

His clinical expertise is in movement disorders including Parkinson’s disease. Dr. Kang studies the molecular and cellular mechanisms of brain circuit plasticity underlying both beneficial and detrimental effects of dopaminergic therapy such as dyskinesia using pre-clinical models with cell type-specific modulation and recording, correlated with behaviors. Dr. Kang is also interested in biomarker development in Parkinson’s disease and related disorders. He led the Fox Investigation for New Discovery of Biomarkers (BioFIND) and serves on biospecimen review committees for The Michael J. Fox Foundation’s Parkinson’s Progression Markers Initiative and the National Institutes of Health Parkinson's Disease Biomarker Program.


Associated Grants

  • White Blood Cell and Urine Collection in LRRK2 and GBA Mutation Carriers

    2017


  • Development of a Biomarker Assay for Oxidized DJ-1 in Parkinson’s Disease

    2014


  • Role of Striatal Cholinergic Interneurons in Parkinson’s Disease Dyskinesia

    2014


  • Gene Expression Changes in Striatal Cholinergic Interneurons Associated with Levodopa-induced Dyskinesia

    2014


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.